Non ci sono recensioni
Comprehensive resource summarizing recent research on von Willebrand disease, showing clinicians how to optimize management of patients with this disorder
The newly revised and updated second edition of Textbook of von Willebrand Disease: Basic and Clinical Aspects, 2nd edition describes the important and complex role of von Willebrand factor (VWF) in hemostasis and thrombosis, covering not only the current understanding of its molecular biology, but also the association between genetic variants of VWF and different von Willebrand disease (VWD) phenotypes. The text also reviews the important area of the obstetric and gynecological manifestations of VWD, as well as how to manage patients with VWD for surgery.
Many advances in agents are included in this updated edition, as well as the wide topics such as VWF in Angiogenesis, and VWF/ADAMTS13 as risk factors of thrombosis.
Edited by a team of experts in VWD an international team of contributors, Textbook of Von Willebrand Disease covers sample topics such as:
Providing complete and accessible coverage of the subject, Textbook of von Willebrand Disease: Basic and Clinical Aspects, 2nd edition is a valuable resource for hematologists in practice and in training, along with specialists in thrombosis, hemostasis, and bleeding/clotting disorders.
List of Contributors, vii
Foreword, xi
Preface, xiii
1 Historical perspective on von Willebrand disease, 1
Erik E. Berntorp and Margareta Blombäck
2 Biosynthesis and organization of von Willebrand factor, 7
Sandra L. Haberichter
3 Von Willebrand factor structure and function, 23
Robert R. Montgomery, Veronica H. Flood, and Sandra L. Haberichter
4 Regulation of von Willebrand factor expression, 39
Elham Ghorbanpour and David Lillicrap
5 Modulation of VWF by ADAMTS13, 49
Yaoxian Xu, Anastasis Petri, and James T.B. Crawley
6 Assessment of VWF clearance, 63
Orla Rawley, Laura L. Swystun, and Jamie M. O’Sullivan
7 Classification of VWD, 73
Jessica Garcia, Sandra L. Haberichter, and Veronica H. Flood
8 The epidemiology of von Willebrand disease, 81
Giancarlo Castaman and Francesco Rodeghiero
9 Clinical aspects of von Willebrand disease: bleeding history, 87
Paula D. James and Alberto Tosetto
10 Laboratory diagnosis of von Willebrand disease: the phenotype, 95
Emmanuel J. Favaloro and Ulrich Budde
11 Molecular diagnosis of von Willebrand disease: the genotype, 109
Pamela Christopherson, Robert R. Montgomery, and Veronica H. Flood
12 Clinical, laboratory, and molecular markers of type 1 von Willebrand disease and low von Willebrand factor, 115
David Lillicrap
13 Clinical and molecular markers of type 1C VWD, 123
Heather Clift, Veronica H. Flood, and Sandra L. Haberichter
14 Clinical and molecular markers of VWD2A, 129
Reinhard Schneppenheim and Giancarlo Castaman
15 Clinical and molecular markers of VWD2B, 137
Giancarlo Castaman and Augusto B. Federici
16 Clinical and molecular markers of type 2M VWD, 143
Maissaa Janbain, Sandra L. Haberichter, and Veronica H. Flood
17 Clinical and molecular markers of VWD2N, 149
Jenny Goudemand and Mélanie Daniel
18 Clinical, laboratory, and molecular markers of type 3 von Willebrand disease, 159
Luciano Baronciani and Augusto B. Federici
19 Pediatric aspects of von Willebrand disease, 177
Robert F. Sidonio Jr and Jorge Di Paola
20 Women with von Willebrand Disease, 185
Rezan Abdul Kadir
21 The use of desmopressin in von Willebrand disease, 201
Giancarlo Castaman and Augusto B. Federici
22 Plasma-derived and recombinant VWF concentrates, 215
Pier Mannuccio Mannucci and Massimo Franchini
23 Pathophysiology, epidemiology, and management of acquired von Willebrand syndrome, 221
Ulrich Budde and Augusto B. Federici
24 Cardiovascular causes of AVWS, 239
Antoine Rauch and Sophie Susen
25 Von Willebrand factor regulation of angiogenesis and vascular integrity: implications for gastrointestinal angiodysplasia and beyond, 247
Anna M. Randi and Giancarlo Castaman
26 Prophylaxis in von Willebrand disease, 257
Erik E. Berntorp and Augusto B. Federici
27 Risk of thrombosis and antithrombotic treatment in von Willebrand disease patients, 265
Ferdows Atiq and Frank W.G. Leebeek
28 Novel functions for VWF beyond hemostasis, 271
Ferdows Atiq and James S. O'Donnell
Index, 281
Sei sicuro di voler eseguire questa azione?